TeamNet and Latest updates 2. Cardiovascular System Guidelines
Anticoagulation Guidance
BNSSG DOAC decision aid March 2020
BNSSG Summary of considerations when prescribing a DOAC
Anticoagulant and antiplatelet co–prescribing information
BNSSG Anticoagulation questions and answers July 2013
NBT NOAC counselling checklist
NICE KTT16 Anticoagulants including DOACs Updated Sep 2016
UHB Anticoagulants Counselling Jan 13
UKMI Oral Anticoagulants in AF
Anticoagulation Patient Information Leaflets
Anticoagulation in AF
Anticoagulation patient information leaflet 2018
BNSSG Apixaban in AF Leaflet April 13
BNSSG Apixaban in AF Leaflet for printing April 13
BNSSG Dabigatran in AF Leaflet July 12
BNSSG Dabigatran in AF Leaflet for printing July 12
BNSSG Rivaroxaban in AF Leaflet July 12
BNSSG Rivaroxaban in AF Leaflet for printing July 12
Anticoagulation in DVT
Anticoagulation choices leaflet v2 in DVT June 15 –final – for printing (rotated version)
Anticoagulation choices v2 in DVT June 15–final unrotated
Antiplatelet Guidance
Antiplatelet Guidelines May 17 BNSSG
Ticagrelor AGWS cardiac network guidelines Sept 12
Statin Guidance
BNSSG Management of Blood Lipid Levels (Statin Guidelines) 2020
Heart Failure Guidance
Primary care heart failure guidelines
Raynaud's Phenomenon
Due to significant disruption with the supply of a number of Nifedipine preparations, see local advice document on alternative options for the management of Raynaud's Phenomenon, available here
Medical Management of Raynauds Phenomenon in view of Nifedipine supply changes (Nov 19).pdf